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  EVIDENCE-BASED ANSWER 
Stress radionuclide testing is a moderately accurate test compared with coronary angiography for the diagnosis 
of coronary artery disease (CAD) in intermediate-risk individuals. 
Variations in technique of imaging (planar or single-photon emission computed tomography [SPECT]) and 
stress (exercise or pharmacologic) do not significantly alter the accuracy of this test, although there is some 
evidence for decreased accuracy in women (strength of recommendation [SOR]: A, based on multiple meta-
analyses). Abnormal stress radionuclide screening in vascular surgical candidates also predicts an increased 
rate of perioperative cardiac events (SOR: A, based on meta-analysis). 
  EVIDENCE SUMMARY 
Stress radionuclide imaging—specifically its diagnostic accuracy—has been the subject of numerous studies. 
Detrano et al1 reported the first pooled data (56 studies); they concluded that estimates of sensitivity (85%) and 
specificity (85%) are biased by studies that were not blinded, included subjects with prior myocardial infarction 
(MI), or had a work-up (verification) bias (ie, use of the gold standard test is affected by the result on the test 
under question). 
Another systematic review reported estimates of sensitivity ranging from 68% to 96% and specificity from 65% 
to 100%.2 The review was accompanied by a position paper from the American College of Physicians stating 
that the test may be appropriate for a patient with intermediate risk of coronary artery disease.3 
Four meta-analyses report diagnostic accuracy of radionuclide cardiac imaging (Table). Kwok et al6 analyzed 
data on women only and found decreased diagnostic accuracy in this population. Kim et al7 analyzed 
pharmacologic stressors used with SPECT and confirmed that accuracy is near that of exercise SPECT. 
Patient-centered outcomes were reported in a meta-analysis of dipyridamole-thallium imaging in the 
preoperative evaluation of vascular surgery patients. The summary odds ratio for any perioperative cardiac 
event (in patients with abnormal tests) was 3.5 (95% confidence interval [CI], 2.5–4.8); the odds ratio for MI or 
cardiac death was 3.9 (95% CI, 2.5–5.6), leading the authors to conclude that there is sound evidence to use 
radionuclide testing in intermedi.ate-risk patients during preoperative screening.8 
 
TABLE 
Diagnostic accuracy reported in meta-analyses of cardiac radionuclide 
SPECT imaging 
Authors, year Studies 
Sn % 
(95% CI) 
Sp % 
(95% 
CI) 
LR+ LR– 
Garber and 
Solomon 19944 
8 
88 (73–
98) 
77 (53–
96) 
3.8 0.16 
Fleischmann et al, 
et al 19985 
27 
87 (86–
88) 
64 (60–
68) 
2.4 0.20 
Kwok et al, 19966 3 
78 (69–
87) 
58 (51–
66) 
1.9 0.38 
Kim et al, 20017 44 90 (89–
92)* 
75 (70–
79)* 
3.6 0.13 
89 (84–
93)† 
65 (54–
74)† 
2.5 0.17 
82(77–
87)‡ 
73 (70–
79)‡ 
3.0 0.25 
*Adenosine SPECT 
†Dipyridamole SPECT 
‡Dobutamine SPECT 
SPECT, single-photon emission computed tomography; SN, sensitivity; Sp, specifity; LR+, 
positive likelihood ratio; LR–, negative likelihood ratio; Cl, confidence interval 
  RECOMMENDATIONS FROM OTHERS 
The American Heart Association/American College Cardiology (AHA/ACC) Task Force on Assessment of 
Diagnostic and Therapeutic Cardiovascular Procedures and the American Society of Nuclear Cardiology 
updated guidelines for cardiac radionuclide imaging in 2003. In this consensus statement (a nonsystematic 
review of literature and expert opinion), they reported test characteristics to detect a 50% angiographic lesion 
as follows—exercise SPECT: sensitivity 87%, specificity 73%; vasodilator (adenosine or dipyridamole) SPECT: 
sensitivity 89%, specificity 75%. They noted that quantitative analysis performs as well as qualitative analysis 
of radionuclide images. Gated SPECT is slightly more specific and just as sensitive as nongated SPECT. 
The Taskforce recommended that radionuclide perfusion scans be performed in patients with baseline 
electrocardiogram (ECG) abnormalities (such as left bundle branch block, hypertrophy, digitalis effect, etc), 
patients who cannot perform an exercise stress test, and to assess the functional effect of indeterminate 
lesions found on angiography. They also note that the repeat use of radionuclide testing 3 to 5 years after an 
event in asymptomatic high-risk patients and the initial use of radionuclide testing in patients at very high risk 
are both somewhat controversial, but the weight of limited evidence suggests some benefit to their use.9 
CLINICAL COMMENTARY 
ECG stress still the choice; image those with 
abnormal ECG or unable to exercise 
 
David  Kilgore,  MD 
Tacoma Family Medicine,Tacoma, Wash 
Primary care providers frequently face the question of how best to evaluate patients with 
suspected CAD. Recent studies and expert opinion appear to give conflicting advice 
regarding the merits of plain exercise ECG vs stress imaging. Information on accuracy 
doesn’t always indicate which test is best for a patient. 
Though quoted sensitivities and specificities for exercise ECG typically appear lower than 
those for stress imaging, costs for stress imaging are significantly higher, and numerous 
recent studies are demonstrating mortality outcome differences obtainable from 
physiologic information found in exercise testing (exercise capacity, blood pressure and 
pulse changes, time to angina). 
Currently, the best choice for evaluation appears to be summarized by the 2003 AHA/ACC 
practice guidelines, which endorse exercise ECG for patients (women included) with 
intermediate pretest risk, and normal resting ECG for those who are unable to exercise. 
Stress imaging is cost effective for those patients with abnormal baseline ECG (left bundle 
branch block, ST abnormalities), or who are unable to exercise. 
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